Virpax Pharmaceuticals, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
OTC.Pink
Director Katharyn Field acquired 2,500 stock options in Virpax Pharmaceuticals on July 5, 2024, at an exercise price of $0.578.
OTC.Pink
Director Gary L. Herman of Virpax Pharmaceuticals acquired stock options on July 5, 2024, according to a Form 4 filing with the SEC.
OTC.Pink
Director Jatinder Dhaliwal reports acquisition of stock options in Virpax Pharmaceuticals, Inc.